Cargando…

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

A new live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) has been developed based on innovative technology to give protection against JE with an improved immunogenicity and safety profile. In this phase 3, observer-blind study, 274 children aged 12−24 months were randomized 1:1 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Soo, Houillon, Guy, Jang, Gwang Cheon, Cha, Sung-Ho, Choi, Soo-Han, Lee, Jin, Kim, Hwang Min, Kim, Ji Hong, Kang, Jin Han, Kim, Jong-Hyun, Kim, Ki Hwan, Kim, Hee Soo, Bang, Joon, Naimi, Zulaikha, Bosch-Castells, Valérie, Boaz, Mark, Bouckenooghe, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977450/ https://www.ncbi.nlm.nih.gov/pubmed/25483480 http://dx.doi.org/10.4161/hv.29743

Ejemplares similares

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
por: Kwon, Hyo Jin, et al.
Publicado: (2015)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014)

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019)

Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(®)) in South Korea, 2015–2019
por: Kim, Hee Soo, et al.
Publicado: (2020)

Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization
por: Feroldi, Emmanuel, et al.
Publicado: (2017)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
por: Li, Guohua, et al.
Publicado: (2021)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab(®)): A Systematic Review of Intradermal Use Between 1985 and 2019
por: Moulenat, Thomas, et al.
Publicado: (2020)

Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14
por: Kim, Soo Jin, et al.
Publicado: (2017)

Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
por: Kim, Young-Jae, et al.
Publicado: (2010)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
por: Yun, Sang-Im, et al.
Publicado: (2014)

Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome
por: Lee, Jong-Mi, et al.
Publicado: (2019)

Vacciné, ai-je assez d’anticorps ?
por: Dalmat, Yann-Mickael
Publicado: (2021)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
por: Erra, Elina O., et al.
Publicado: (2013)

Vaccine-associated Paralytic Poliomyelitis : A Case Report of Flaccid Monoparesis after Oral Polio Vaccine
por: Kim, Sun Jun, et al.
Publicado: (2007)

Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively?
por: Park, Sung Hee, et al.
Publicado: (2014)

"Vers 14 ans, j'additionnais ou multipliais les nombres que je voyais"
Publicado: (2005)

A 14-week randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy and safety of ginseng polysaccharide (Y-75)
por: Cho, Young-Jin, et al.
Publicado: (2014)

An evaluation of the anti-angiogenic effect of the Korean medicinal formula “Sa-mi-yeon-geon-tang” in vitro and in ovo
por: Yi, Jin-Mu, et al.
Publicado: (2015)

Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer
por: Kim, Sauryang, et al.
Publicado: (2016)

Vaccination strategies for Korean patients with inflammatory bowel disease
por: Lee, Yoo Jin, et al.
Publicado: (2022)

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo
por: Noh, Kyungseob, et al.
Publicado: (2022)

USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro
por: Han, Kyung Ho, et al.
Publicado: (2019)

Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14
por: Jeong, Seung Chan, et al.
Publicado: (2005)

In Memory of Professor Je Geun Chi, a Great Mentor and Pathologist
por: Kim, Chong Jai
Publicado: (2015)

Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals
por: Yoon, Chang-gyo, et al.
Publicado: (2017)

Comparison of Waning Immunity Between Booster Vaccination and 2-Dose Vaccination With BNT162b2
por: Jung, Jiwon, et al.
Publicado: (2022)

A Single Dose of Vero Cell–Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain–Derived JE Vaccines
por: Erra, Elina O., et al.
Publicado: (2012)

Je : roman /
por: Velan, Yves, 1925-
Publicado: (1990)

‘Als je de hele dag staat, moet je je voeten goed verzorgen’
por: van der Zee, Margriet
Publicado: (2020)

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9n7grmv1nt64kcsa35f7r3fqha